Brigit Biofarmaka Teknologi Tbk. vs Semacom Integrated Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume), while Semacom Integrated Tbk. trades at Rp146 (market cap 177.84B, 83.16M 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. and Semacom Integrated Tbk. are close in size by market cap, and Semacom Integrated Tbk. is more actively traded (83.16M versus 324K). Which is the better fit depends on your goals.
| OBAT | SEMA | |
|---|---|---|
Market Cap | 166.01B | 177.84B |
Volume | 324K | 83.16M |
Lot | 3.24K | 831.61K |
Turnover | 77.68M | 12.19B |
Average Price | 239.75 | 146.55 |
Value | 77.68M | 12.19B |
Indicative Equilibrium Price | 240 | 146 |
Indicative Equilibrium Volume | 1 | 8.23K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Semacom Integrated Tbk (the Company) was established in the Republic of Indonesia on October 01, 2009 based on Notarial deed No. 5 of H. Dana Sasmita, S.H, Notary in Jakarta The Company begin opertions commercial activities since 2009.
Read more on SEMA →